• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Epha5 突变会损害自然杀伤细胞对非小细胞肺癌细胞的细胞毒性,并促进癌细胞的迁移和侵袭。

EPHA5 mutation impairs natural killer cell-mediated cytotoxicity against non-small lung cancer cells and promotes cancer cell migration and invasion.

机构信息

Department of Geriatric Respiratory and Sleep, Henan Institute of Respiratory Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.

Department of Infectious Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.

出版信息

Mol Cell Probes. 2020 Aug;52:101566. doi: 10.1016/j.mcp.2020.101566. Epub 2020 Mar 28.

DOI:10.1016/j.mcp.2020.101566
PMID:32234341
Abstract

AIM

This study aims to evaluate the role of the EPHA5 mutation in the migration and invasion of non-small cell lung cancer (NSCLC) cells and in modulating the killing effect of natural killer (NK) cells to NSCLC cells.

METHODS

EPHA5-wt (wild type) and EPHA5-mut (mutation) plasmids were constructed. EPHA5 was silenced using si-EPHA5. NSCLC cell migration and invasion were determined using Transwell assays. NK cell proliferation and apoptosis were determined using CCK-8 assay and flow cytometry, respectively. The killing effect of NK cells to NSCLC cells was also examined.

RESULTS

EPHA5 mutation significantly promoted migration and invasion in NSCLC cells. Furthermore, EPHA5 mutation notably impaired the cytotoxicity of NK cells against NSCLC cells. In contrast, EPHA5-wt overexpression and EPHA5 silencing exerted the opposite effect.

CONCLUSION

EPHA5 mutation impairs the NK cell-mediated cytotoxicity against NSCLC cells and promotes migration and invasion in NSCLC cells.

摘要

目的

本研究旨在评估 EphA5 突变在非小细胞肺癌(NSCLC)细胞迁移和侵袭中的作用,以及调节自然杀伤(NK)细胞对 NSCLC 细胞杀伤作用的机制。

方法

构建 EphA5-wt(野生型)和 EphA5-mut(突变型)质粒。使用 si-EPHA5 沉默 EphA5。通过 Transwell 实验检测 NSCLC 细胞的迁移和侵袭。使用 CCK-8 法和流式细胞术分别检测 NK 细胞的增殖和凋亡。还检测了 NK 细胞对 NSCLC 细胞的杀伤作用。

结果

EphA5 突变显著促进了 NSCLC 细胞的迁移和侵袭。此外,EphA5 突变明显削弱了 NK 细胞对 NSCLC 细胞的细胞毒性。相比之下,EphA5-wt 过表达和 EphA5 沉默则产生了相反的效果。

结论

EphA5 突变削弱了 NK 细胞对 NSCLC 细胞的杀伤作用,并促进了 NSCLC 细胞的迁移和侵袭。

相似文献

1
EPHA5 mutation impairs natural killer cell-mediated cytotoxicity against non-small lung cancer cells and promotes cancer cell migration and invasion.Epha5 突变会损害自然杀伤细胞对非小细胞肺癌细胞的细胞毒性,并促进癌细胞的迁移和侵袭。
Mol Cell Probes. 2020 Aug;52:101566. doi: 10.1016/j.mcp.2020.101566. Epub 2020 Mar 28.
2
Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis.长链非编码 RNA PRNCR1 通过 PRNCR1/miR-126-5p/MTDH 轴调节非小细胞肺癌细胞的增殖、凋亡、迁移、侵袭和 EMT。
Biosci Rep. 2020 Jul 31;40(7). doi: 10.1042/BSR20193153.
3
SNHG14 silencing suppresses the progression and promotes cisplatin sensitivity in non-small cell lung cancer.SNHG14 沉默抑制非小细胞肺癌的进展并增强顺铂敏感性。
Biomed Pharmacother. 2019 Sep;117:109164. doi: 10.1016/j.biopha.2019.109164. Epub 2019 Jun 26.
4
Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.敲低长链非编码 RNA DLX6-AS1 通过下调 PRR11 表达和上调 miR-144 抑制非小细胞肺癌细胞增殖、迁移和侵袭,促进细胞凋亡。
Biomed Pharmacother. 2019 Jan;109:1851-1859. doi: 10.1016/j.biopha.2018.09.151. Epub 2018 Nov 26.
5
Ephrin B3 interacts with multiple EphA receptors and drives migration and invasion in non-small cell lung cancer.Ephrin B3与多种EphA受体相互作用,并驱动非小细胞肺癌的迁移和侵袭。
Oncotarget. 2016 Sep 13;7(37):60332-60347. doi: 10.18632/oncotarget.11219.
6
Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.长链非编码 RNA linc00673 通过海绵吸附 miR-150-5p 调控非小细胞肺癌增殖、迁移、侵袭和上皮间质转化。
Mol Cancer. 2017 Jul 11;16(1):118. doi: 10.1186/s12943-017-0685-9.
7
Inhibition of TrxR2 suppressed NSCLC cell proliferation, metabolism and induced cell apoptosis through decreasing antioxidant activity.抑制硫氧还蛋白还原酶2(TrxR2)可通过降低抗氧化活性来抑制非小细胞肺癌(NSCLC)细胞的增殖、代谢并诱导细胞凋亡。
Life Sci. 2017 Jun 1;178:35-41. doi: 10.1016/j.lfs.2017.04.008. Epub 2017 Apr 14.
8
Low miR-145 silenced by DNA methylation promotes NSCLC cell proliferation, migration and invasion by targeting mucin 1.通过DNA甲基化沉默的低水平miR-145通过靶向粘蛋白1促进非小细胞肺癌细胞的增殖、迁移和侵袭。
Cancer Biol Ther. 2015;16(7):1071-9. doi: 10.1080/15384047.2015.1046024. Epub 2015 May 11.
9
MicroRNA-130a enhances the killing ability of natural killer cells against non-small cell lung cancer cells by targeting signal transducers and activators of transcription 3.微小 RNA-130a 通过靶向信号转导子和转录激活子 3 增强自然杀伤细胞对非小细胞肺癌细胞的杀伤能力。
Biochem Biophys Res Commun. 2020 Mar 5;523(2):481-486. doi: 10.1016/j.bbrc.2019.11.099. Epub 2019 Dec 27.
10
LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.长链非编码 RNA SNHG1 通过 miR-361-3p/FRAT1 轴影响非小细胞肺癌细胞的增殖、迁移、侵袭和凋亡。
Thorac Cancer. 2020 Feb;11(2):295-304. doi: 10.1111/1759-7714.13256. Epub 2019 Dec 2.

引用本文的文献

1
Integrated radiomics and immune infiltration analysis to decipher immunotherapy efficacy in lung adenocarcinoma.整合放射组学与免疫浸润分析以解读肺腺癌的免疫治疗疗效
Quant Imaging Med Surg. 2025 Apr 1;15(4):3123-3147. doi: 10.21037/qims-24-130. Epub 2025 Mar 28.
2
Case report: A panorama gene profile of ovarian cancer metastasized to axillary lymph node.病例报告:一例卵巢癌转移至腋窝淋巴结的全景基因图谱。
Front Immunol. 2025 Jan 24;16:1548102. doi: 10.3389/fimmu.2025.1548102. eCollection 2025.
3
Comprehensive analysis of Epha10 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in non-small cell lung cancer.
全面分析 EphA10 作为非小细胞肺癌临床预后和免疫检查点治疗疗效的预测因子。
Sci Rep. 2024 Aug 23;14(1):19623. doi: 10.1038/s41598-024-70466-8.
4
The genomic landscape of the immune system in lung cancer: present insights and continuing investigations.肺癌中免疫系统的基因组格局:当前见解与持续研究
Front Genet. 2024 Jun 25;15:1414487. doi: 10.3389/fgene.2024.1414487. eCollection 2024.
5
Synthesis and antibacterial activity studies of indirubin-3'-monoximes.靛玉红-3'-单肟的合成与抗菌活性研究
RSC Adv. 2022 Sep 2;12(38):25068-25080. doi: 10.1039/d2ra01035f. eCollection 2022 Aug 30.
6
EPHA5 mutation was associated with adverse outcome of atezolizumab treatment in late-stage non-small cell lung cancers.Epha5 突变与晚期非小细胞肺癌患者接受阿特珠单抗治疗的不良预后相关。
BMC Pulm Med. 2022 Sep 19;22(1):356. doi: 10.1186/s12890-022-02161-1.
7
The oncogenic landscape of the idiopathic pulmonary fibrosis: a narrative review.特发性肺纤维化的致癌格局:一项叙述性综述。
Transl Lung Cancer Res. 2022 Mar;11(3):472-496. doi: 10.21037/tlcr-21-880.
8
Analyzing the characteristics of immune cell infiltration in lung adenocarcinoma via bioinformatics to predict the effect of immunotherapy.通过生物信息学分析肺腺癌免疫细胞浸润的特征,预测免疫治疗的效果。
Immunogenetics. 2021 Oct;73(5):369-380. doi: 10.1007/s00251-021-01223-8. Epub 2021 Jul 24.
9
Mucinous adenocarcinoma caused by cancerization from a ciliated multinodular papilloma tumor: A case report.黏液性腺癌源于纤毛多结节乳头状瘤肿瘤的癌变:病例报告。
Thorac Cancer. 2021 May;12(10):1629-1633. doi: 10.1111/1759-7714.13956. Epub 2021 Apr 3.
10
Molecular Profiling of Exceptional Responders to Cancer Therapy.癌症治疗中极具疗效反应者的分子剖析。
Oncologist. 2021 Mar;26(3):186-195. doi: 10.1002/onco.13600. Epub 2020 Nov 28.